South & Central America Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The South & Central America neurorehabilitation devices market was valued at US$ 104.24 million in 2023 and is expected to reach US$ 221.17 million by 2031; it is estimated to register a CAGR of 9.9% from 2023 to 2031.

Strategic Initiatives by Market Players Fuel South & Central America Neurorehabilitation Devices Market

Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand market reach.

In April 2022, Blackrock Neurotech partnered with Phantom Neuro, a neurotech startup, to carry out R&D for Phantom Neuro's patent-pending Phantom X system, which offers patients highly accurate, almost real-time control of current and next-generation assistive devices, such as prosthetics and exoskeletons. This R&D partnership allows Phantom to use Blackrock's decades of experience in neurotechnology and develop biocompatible implantable sensors to complement and bolster the Phantom X platform.

In December 2022, Ekso Bionics-a leader in exoskeleton technology for medical use-announced the acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation. This acquisition will enhance Ekso's product portfolio and improve its strategic relationships with commercial and research partners such as Vanderbilt University. The partnership with Vanderbilt is expected to enhance its research capabilities and product development.

Thus, the strategic initiatives taken by the market players are likely to create lucrative opportunities for the neurorehabilitation market in the near future.

South & Central America Neurorehabilitation Devices Market Overview

The South & Central America neurorehabilitation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America and Brazil hold the largest market share. The prevalence of a few neurological diseases has been associated with the aging population in Brazil. According to the Pan American Health Organization in 2022, the country has more than 30 million older adults aged 60 years and above, representing 13% of the country's population. By 2030, the number of people from this age group will reach nearly 50 million, which will be 24% of the total Brazilian population. The World Health Organization (WHO) and the Brazilian Institute of Geography and Statistics reported that the geriatric population in Brazil (aged 60 years and older) is expected to reach ~55 million by 2040. Thus, the increasing incidences of neurological diseases, such as Parkinson's disease, are likely to propel the demand for neurorehabilitation in the coming years. Many institutes in Brazil are working toward the growth of neuroscience in Brazil.

South & Central America Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Neurorehabilitation Devices Market Segmentation

The South & Central America neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the South & Central America neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

In terms of application, the South & Central America neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's Disease, cerebral palsy, and others. The stroke segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

By end user, the South & Central America neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

Based on country, the South & Central America neurorehabilitation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America neurorehabilitation devices Market in 2023.

Abbott Laboratories; BIONIK; BioXtreme Ltd; Blackrock Microsystems Inc; Ekso Bionics Holdings Inc; EMOTIV; Hocoma AG; Medtronic Plc; Renishaw Plc; and Tyromotion GmbH are some of the leading companies operating in the South & Central America neurorehabilitation devices market.

Product Code: BMIRE00031469

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:
3.3 Assumptions and Limitations

4. South and Central America Neurorehabilitation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price

5. South and Central America Neurorehabilitation Devices Market - Key Market Dynamics

5.1 South and Central America Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Neurological Diseases
- 5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
- 5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:

6. South and Central America Neurorehabilitation Devices Market - Analysis

6.1 South and Central America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 South and Central America Neurorehabilitation Devices Market Forecast Analysis

7. South and Central America Neurorehabilitation Devices Market Analysis - by Product Type

7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South and Central America Neurorehabilitation Devices Market Analysis - by Application

8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
- 8.4.1 Overview
- 8.4.2 Parkinson's Disease: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South and Central America Neurorehabilitation Devices Market Analysis - by End User

9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South and Central America Neurorehabilitation Devices Market - Country Analysis

10.1 South and Central America
- 10.1.1 South and Central America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South and Central America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South and Central America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.2.2 Brazil: South and Central America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.2.3 Brazil: South and Central America Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.3 Argentina: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South and Central America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.3.2 Argentina: South and Central America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.3.3 Argentina: South and Central America Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.4 Rest of South and Central America: South and Central America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South and Central America: South and Central America Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.4.2 Rest of South and Central America: South and Central America Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.4.3 Rest of South and Central America: South and Central America Neurorehabilitation Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations

12. Company Profiles

12.1 Blackrock Microsystems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hocoma AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Tyromotion GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BIONIK
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Renishaw Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 EMOTIV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BioXtreme Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms